Search company, investor...

Predict your next investment

INKEF Capital company logo
Venture Capital
inkef.com

Investments

79

Portfolio Exits

17

Funds

1

About INKEF Capital

INKEF Capital provides long-term capital and business advice to starting entrepreneurs in the Netherlands. It provides seed capital to turn an idea into a company or provides growth capital to give a running start-up the next push. The company was founded in 2010 and is based in Amsterdam, Netherlands.

Headquarters Location

ITO toren Gustav Mahlerplein 104

Amsterdam, 1082,

Netherlands

+31 (0)20 79 46 060

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest INKEF Capital News

NMD Pharma Raises €75 Million Series B

Nov 21, 2023

NMD Pharma, an Aarhus-based biotech company, secured €75 million in a Series B financing led by Jeito Capital, with contributions from existing investors such as Novo Holdings, Lundbeckfonden BioCapital, INKEF Capital, and the Roche Venture Fund. Specializing in developing innovative treatments for neuromuscular diseases, NMD Pharma focuses on creating first-in-class ClC-1 molecule inhibitors to restore […]

INKEF Capital Investments

79 Investments

INKEF Capital has made 79 investments. Their latest investment was in Silverflow as part of their Series B on November 11, 2023.

CBI Logo

INKEF Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/16/2023

Series B

Silverflow

$16.25M

No

4

11/15/2023

Series B

NMD Pharma

$80M

No

3

5/25/2023

Series B - II

VarmX

$32.16M

No

2

5/2/2023

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

3/9/2023

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/16/2023

11/15/2023

5/25/2023

5/2/2023

3/9/2023

Round

Series B

Series B

Series B - II

Seed VC - II

Series B

Company

Silverflow

NMD Pharma

VarmX

Subscribe to see more

Subscribe to see more

Amount

$16.25M

$80M

$32.16M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

3

2

10

10

INKEF Capital Portfolio Exits

17 Portfolio Exits

INKEF Capital has 17 portfolio exits. Their latest portfolio exit was Cashforce on June 16, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/16/2022

Acquired

$99M

1

4/25/2022

Acquired

$99M

3

2/7/2022

Acquired

$99M

4

1/24/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

10/21/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/16/2022

4/25/2022

2/7/2022

1/24/2022

10/21/2021

Exit

Acquired

Acquired

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

3

4

10

10

INKEF Capital Fund History

1 Fund History

INKEF Capital has 1 fund, including Inkef Capital.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/7/2016

Inkef Capital

$561.95M

2

Closing Date

9/7/2016

Fund

Inkef Capital

Fund Type

Status

Amount

$561.95M

Sources

2

INKEF Capital Team

5 Team Members

INKEF Capital has 5 team members, including current Chief Executive Officer, Michael Stam.

Name

Work History

Title

Status

Michael Stam

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Michael Stam

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.